Vedanta Biosciences Highlights Microbiome Therapeutics at ESCMID 2026
Vedanta Biosciences Highlights Advances in Microbiome-Based Therapeutics at ESCMID 2026 Global Congress Vedanta Biosciences, a late clinical-stage biopharmaceutical company focused on developing microbiome-based oral therapies for gastrointestinal diseases, has announced…
Charles River Promotes Cardiovascular Health Awareness Through Support of the American Heart Association
Charles River Promotes Cardiovascular Health Awareness with Support for the American Heart Association Charles River Laboratories International, Inc. (NYSE: CRL) has announced a new collaboration with the American Heart Association,…
Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer, Expanding Multimedia Integration
Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer, Strengthening Leadership with Multimedia Announcement Byondis B.V., an independent biotechnology company focused on the development of innovative targeted therapies for…
Emalex Secures U.S. Patent for Orally Disintegrating Ecopipam Formulation
Emalex Awarded U.S. Patent for Its Orally Disintegrating Ecopipam Formulation Emalex Biosciences has announced a significant advancement in its drug development efforts with the issuance of a new patent by…
Almost Half of Adults in the Community May Be Living with Undiagnosed Prediabetes
A Significant Proportion of Adults in the Community May Be Unaware They Are Living with Prediabetes The El Camino Healthcare District has launched a comprehensive new initiative aimed at tackling…
Cartherics and Catalent Broaden Commercial Licensing Agreement
Cartherics and Catalent Extend Scope of Existing Commercial Licensing Agreement Cartherics Pty Ltd, a clinical-stage biotechnology company focused on developing next-generation immune cell therapies for high-impact women’s health conditions, has…
CMS Assigns COVID-19–Specific HCPCS Codes for Fresenius Kabi’s Tyenne® (tocilizumab-aazg)
Fresenius Kabi Receives CMS Approval for COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg) Fresenius Kabi, a subsidiary of Fresenius and a global leader in essential medicines and medical technologies, has…
Join 1,000+ Professionals at the Emergency Medicine Conference 2026
Join over 1,000 emergency medicine professionals from across the globe at the Annual Conference 2026, taking place in Birmingham on 28–30 April, as we come together to shape the future of the specialty. With a…
Cosette Pharmaceuticals Expands Branded Portfolio with SYMPAZAN® and Other Asset Acquisition from Assertio
Cosette Pharmaceuticals Broadens Branded Portfolio with Acquisition of SYMPAZAN® and Additional Assets from Assertio Cosette Pharmaceuticals has announced the successful closing of a strategic acquisition that significantly expands its branded…
Assertio to Be Acquired by Garda Therapeutics in Strategic Deal
Assertio Enters Definitive Agreement for Acquisition by Garda Therapeutics Assertio Holdings Inc. has announced a transformative set of transactions that will significantly reshape the company’s structure and deliver immediate value…
TAE Life Sciences Reports Breakthrough BNCT Data Showing Durable Tumor Control and Systemic Immune Response
TAE Life Sciences Highlights Breakthrough BNCT Research Showing Sustained Tumor Control and Systemic Immune Effects TAE Life Sciences has announced the publication of new preclinical research in ACS Pharmacology &…
Pilatus Biosciences to Present Sex-Specific CD36 Antibody Data in Colorectal Cancer at AACR 2026
Pilatus Biosciences to Showcase New Data on Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026 Pilatus Biosciences has announced that it will present new preclinical findings at…